Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,529.36
(
0.08%
)
News Focus
News Focus
Post# of 7747
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Steptwice

Send PM Follow Ignore
Followers 3
Posts 147
Boards Moderated 0
Alias Born 05/02/2017

Steptwice

Re: ABBAZABBA post# 4190

Tuesday, 07/18/2017 1:51:23 PM

Tuesday, July 18, 2017 1:51:23 PM

Post# of 7747
But this P2 data is super important bcz I believe if positive enough it can be implemented under a certain application where there will not need to be a P3 trial. Aldox will be allowed to be applied to patient with SCLC w.o. P3.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today